Ascendis Pharma ADR (NQ: ASND )
138.08
+2.37
(+1.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 12, 2024
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore News![]() Performance
More NewsRead More![]() ![]() ![]()
(ASND) - Analyzing Ascendis Pharma's Short Interest
May 28, 2024
Via Benzinga
![]()
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
May 15, 2024
Via Benzinga
Exposures
Product Safety
![]()
Masters In Trading - Saturday, May 11
May 11, 2024
Via Talk Markets
![]()
Looking Into Ascendis Pharma's Recent Short Interest
April 26, 2024
Via Benzinga
![]() ![]() ![]() ![]()
$1000 Invested In This Stock 15 Years Ago Would Be Worth $45,000 Today
February 23, 2024
Via Benzinga
![]()
How Is The Market Feeling About Ascendis Pharma?
February 13, 2024
Via Benzinga
![]() Via Benzinga
![]()
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
March 09, 2024
Via Talk Markets
![]() ![]()
Earnings Scheduled For February 7, 2024
February 07, 2024
Via Benzinga
![]()
Ascendis Pharma's Earnings: A Preview
February 06, 2024
Via Benzinga
![]() Via Benzinga
![]()
Ascendis Pharma's Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial
December 19, 2023
Via Benzinga
![]()
Analyst Expectations for Ascendis Pharma's Future
November 09, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|